🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if the use of exploratory immunol...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Start Date
2013-07-05
Trial ID
NCT01899989
Treatments Being Tested
The hypothesis is that helical tomotherapy could minimize radiation related...
Status
Unknown
Location
Cross Cancer Institute
Start Date
2008-09
Trial ID
NCT00754078
Treatments Being Tested
This phase II trial studies how well chemotherapy before surgery and radiat...
Status
Active Not Recruiting
Location
University of Arizona Cancer Center-Orange Grove Campus
Start Date
2019-03-12
Trial ID
NCT03493425
The purpose of this study is to compare induction chemotherapy (gemcitabine...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2013-11
Trial ID
NCT01872962
Treatments Being Tested
The primary objective of this study is to determine the response rate, tole...
Status
Unknown
Location
Department of Radiation Oncology, Cancer Hospital, Fudan University
Start Date
2009-01
Trial ID
NCT00817583
This phase II trial studies how well radiation therapy with or without cisp...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-11-23
Trial ID
NCT02734537
Treatments Being Tested
A Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory,...
Status
Completed
Location
Institut Curie
Start Date
2017-07-24
Trial ID
NCT03109080
Treatments Being Tested
RATIONALE: Radiation therapy uses high-energy x-rays and other types of rad...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2012-11
Trial ID
NCT01672892
Treatments Being Tested
This is a single-center, open-label, phase I study designed to determine th...
Status
Terminated
Location
Froedtert & the Medical College of Wisconsin
Start Date
2022-10-31
Trial ID
NCT05325281
Determine the doses and schedule appropriate for phase 2 study of sorafenib...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-01-29
Trial ID
NCT02349867